Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-6 of 6 (Search time: 0.009 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Apoptosis, proliferation and inflammation are improved after treatment with the new selective glp-2 receptor agonist, elsiglutide, in a rat model of irinotecan-induced mucositisMayo, B.; Stringer, A.; Bateman, E.; Bowen, J.; Wignall, A.; Wozniak, B.; White, I.; Pietra, C.; Cantoreggi, S.; Keefe, D.; COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress (02 Dec 2014 - 04 Dec 2014 : Melbourne, Vic.)
2011The effect of ErbB inhibition on chemotherapy-induced intestinal damageMayo, B.; Bowen, J.; Stringer, A.; Bateman, E.; Plews, E.; Darby, J.; Boyle, F.; Keefe, D.; International MASCC/ISOO Symposium (2011 : Athens, Greece)
2014The new selective glp-2 receptor agonist, elsiglutide, improves irinotecan-induced diarrhoea and mucositis in the ratMayo, B.; Bateman, E.; Stringer, A.; Plews, E.; Wignall, A.; Wozniak, B.; White, I.; Pietra, C.; Cantoreggi, S.; Keefe, D.; COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress (02 Dec 2014 - 04 Dec 2014 : Melbourne, Vic.)
2013Investigation of effect of nutritional drink on chemotherapy-induced mucosal injury and tumor growth in an established animal modelBateman, E.; Bowen, J.; Stringer, A.; Mayo, B.; Plews, E.; Wignall, A.; Greenberg, N.; Schiffrin, E.; Keefe, D.
2015Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the artVanhoecke, B.; Bateman, E.; Mayo, B.; Vanlancker, E.; Stringer, A.; Thorpe, D.; Keefe, D.
2017Irinotecan-induced mucositis: the interactions and potential role of GLP-2 analoguesMayo, B.; Stringer, A.; Bowen, J.; Bateman, E.; Keefe, D.